{"id":"https://openalex.org/W3213083322","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.804","title":"804 Real-world incidence and impact of pneumonitis in lung cancer patients treated with immune checkpoint inhibitors","display_name":"804 Real-world incidence and impact of pneumonitis in lung cancer patients treated with immune checkpoint inhibitors","publication_year":2021,"publication_date":"2021-11-01","ids":{"openalex":"https://openalex.org/W3213083322","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.804","mag":"3213083322"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2021-sitc2021.804","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.804","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2021-sitc2021.804","pdf_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A841.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A841.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112131256","display_name":"Bruce C. Tiu","orcid":"https://orcid.org/0000-0002-2815-5579","observed_orcids":["https://orcid.org/0000-0002-2815-5579"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bruce Tiu","raw_affiliation_strings":["Harvard Medical School, Boston, MA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harvard Medical School, Boston, MA, United States","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022162371","display_name":"Leyre Zubiri","orcid":"https://orcid.org/0000-0003-4226-7443","observed_orcids":["https://orcid.org/0000-0003-4226-7443"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leyre Zubiri","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA, United States","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022706102","display_name":"James Iheke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James Iheke","raw_affiliation_strings":["University of Alabama at Birmingham SoM, Birmingham, AL, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham SoM, Birmingham, AL, United States","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087912778","display_name":"Vartan Pahalyants","orcid":"https://orcid.org/0000-0003-4671-620X","observed_orcids":["https://orcid.org/0000-0003-4671-620X"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vartan Pahalyants","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA, United States","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023093211","display_name":"Nicholas Theodosakis","orcid":"https://orcid.org/0000-0003-4388-2288","observed_orcids":["https://orcid.org/0000-0003-4388-2288"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicholas Theodosakis","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA, United States","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013906641","display_name":"Pearl Ugwu\u2010Dike","orcid":"https://orcid.org/0000-0002-8742-6930","observed_orcids":["https://orcid.org/0000-0002-8742-6930"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pearl Ugwu-Dike","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA, United States","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047154028","display_name":"Jayhyun Seo","orcid":"https://orcid.org/0000-0002-1599-113X","observed_orcids":["https://orcid.org/0000-0002-1599-113X"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jayhyun Seo","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA, United States","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062872014","display_name":"Kimberly Tang","orcid":"https://orcid.org/0000-0002-7718-2872","observed_orcids":["https://orcid.org/0000-0002-7718-2872"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kimberly Tang","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA, United States","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008479799","display_name":"Ryan Joseph Sullivan","orcid":"https://orcid.org/0000-0001-5344-6645","observed_orcids":["https://orcid.org/0000-0001-5344-6645"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan Sullivan","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA, United States","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083431383","display_name":"Meghan J. Mooradian","orcid":"https://orcid.org/0000-0002-8289-8015","observed_orcids":["https://orcid.org/0000-0002-8289-8015"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Meghan Mooradian","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA, United States","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055719391","display_name":"Yevgeniy R. Semenov","orcid":"https://orcid.org/0000-0002-7387-3094","observed_orcids":["https://orcid.org/0000-0002-7387-3094"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yevgeniy Semenov","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA, United States","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5035343389","display_name":"Kerry Lynn Reynolds","orcid":"https://orcid.org/0000-0002-7793-654X","observed_orcids":["https://orcid.org/0000-0002-7793-654X"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kerry Reynolds","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA, United States","institution_ids":["https://openalex.org/I4210087915"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A841","last_page":"A841"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.8479999899864197},{"id":"https://openalex.org/keywords/pd-1-pd-l1-inhibitors","display_name":"PD-1/PD-L1 inhibitors","score":0.9539999961853027},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.9890000224113464},{"id":"https://openalex.org/keywords/incidence","display_name":"incidence","score":0.6549999713897705},{"id":"https://openalex.org/keywords/health-care-utilization","display_name":"health care utilization","score":0.8889999985694885},{"id":"https://openalex.org/keywords/hospitalization","display_name":"hospitalization","score":0.7429999709129333},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.5730000138282776},{"id":"https://openalex.org/keywords/prednisone","display_name":"prednisone","score":0.7099999785423279},{"id":"https://openalex.org/keywords/corticosteroid-therapy","display_name":"corticosteroid therapy","score":0.7170000076293945},{"id":"https://openalex.org/keywords/bronchoscopy","display_name":"bronchoscopy","score":0.5839999914169312},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.593999981880188},{"id":"https://openalex.org/keywords/real-world-outcomes","display_name":"real-world outcomes","score":0.6499999761581421},{"id":"https://openalex.org/keywords/billing-codes","display_name":"billing codes","score":0.49399998784065247},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.46299999952316284},{"id":"https://openalex.org/keywords/immunotherapy-safety","display_name":"immunotherapy safety","score":0.4309999942779541}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7543708086013794},{"id":"https://openalex.org/C2779524853","wikidata":"https://www.wikidata.org/wiki/Q1284347","display_name":"Pneumonitis","level":3,"score":0.7187848687171936},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5786400437355042},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5583935379981995},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5540873408317566},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.5490543842315674},{"id":"https://openalex.org/C187316915","wikidata":"https://www.wikidata.org/wiki/Q92307203","display_name":"Case fatality rate","level":3,"score":0.5464614033699036},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5030013918876648},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.482170045375824},{"id":"https://openalex.org/C17923572","wikidata":"https://www.wikidata.org/wiki/Q7250160","display_name":"Propensity score matching","level":2,"score":0.4782525599002838},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.45233866572380066},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4138373136520386},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.2357182800769806},{"id":"https://openalex.org/C107130276","wikidata":"https://www.wikidata.org/wiki/Q133805","display_name":"Epidemiology","level":2,"score":0.13870885968208313},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2021-sitc2021.804","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.804","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2021-sitc2021.804","pdf_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A841.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:26a45125332a4e3b99b4c76fcc4b3498","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/26a45125332a4e3b99b4c76fcc4b3498","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2021-sitc2021.804","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.804","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2021-sitc2021.804","pdf_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A841.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3213083322.pdf","grobid_xml":"https://content.openalex.org/works/W3213083322.grobid-xml"},"referenced_works_count":9,"referenced_works":["https://openalex.org/W2508205285","https://openalex.org/W2522337762","https://openalex.org/W2744857567","https://openalex.org/W2768429453","https://openalex.org/W2786816161","https://openalex.org/W2891486030","https://openalex.org/W2893321040","https://openalex.org/W3016407352","https://openalex.org/W4288400169"],"related_works":["https://openalex.org/W4282914332","https://openalex.org/W4391619272","https://openalex.org/W3168828653","https://openalex.org/W4416636436","https://openalex.org/W4404096022","https://openalex.org/W4226272887","https://openalex.org/W4200569369","https://openalex.org/W3132509156","https://openalex.org/W6962101159","https://openalex.org/W4390755486"],"abstract_inverted_index":{"Background":[0],"Immune":[1],"checkpoint":[2,420,450,487,595],"inhibitors":[3,114,199,564],"(ICI)":[4],"generate":[5],"T-cell":[6],"mediated":[7],"anti-tumor":[8],"responses":[9],"that":[10,304,338,383],"are":[11,391],"effective":[12],"across":[13],"numerous":[14],"malignancies,":[15],"but":[16,352],"their":[17],"use":[18],"is":[19,43,326,345,648],"frequently":[20,253],"complicated":[21],"by":[22,151],"immune-related":[23,412],"adverse":[24,413],"events":[25,414],"(irAEs).":[26],"irAEs":[27],"may":[28],"lead":[29],"to":[30,51,63,67,117,159,197,216,332],"treatment":[31],"delays,":[32],"need":[33],"for":[34,188,457,467],"immunosuppression,":[35],"morbidity,":[36],"and":[37,59,72,84,129,157,171,179,248,287,371,388,396,492,524,598,650],"even":[38],"mortality.1\u20133Checkpoint":[39],"inhibitor":[40,421],"pneumonitis":[41,196,220,277,515],"(CIP)":[42],"the":[44,69,152,189,222,269,327,335,339,455,646],"most":[45,153],"common":[46],"cause":[47],"of":[48,74,91,102,126,137,146,168,195,218,260,265,272,315,330,341,381,385,411,425,432,459,469,509,550,602,623],"fatality":[49],"related":[50],"anti-programmed":[52,543],"cell":[53,511,589],"death":[54,512,545],"receptor/ligand":[55],"1":[56,204,513,547],"(PD-1/PD-L1)":[57],"agents,":[58],"can":[60],"be":[61],"difficult":[62],"diagnose.3":[64],"We":[65],"aimed":[66],"characterize":[68],"real-world":[70,358],"incidence":[71,340,597],"management":[73,169],"CIP,":[75,165],"as":[76,78],"well":[77],"its":[79],"impact":[80],"on":[81,366,638,645],"clinical":[82,348,426,428],"course":[83],"healthcare":[85,177,369],"utilization,":[86,370],"in":[87,176,200,221,258,356,374,415,516,539,570,587,626],"a":[88,95,124,181,312,489,521],"large":[89,394],"cohort":[90,185],"ICI":[92,207,255],"patients":[93,106,148,261,275,416,517,540,592],"using":[94,141,393],"multi-institutional":[96],"database.":[97],"Methods":[98],"Propensity":[99],"score-matched":[100,184],"cohorts":[101],"14,461":[103],"lung":[104,201,375,568,590,627],"cancer":[105,202,520,571,591],"who":[107],"did":[108,110],"or":[109],"not":[111],"receive":[112],"PD-1/PD-L1":[113,198,273],"between":[115],"2014":[116],"2021":[118],"were":[119,252],"identified":[120],"from":[121,132,454],"TriNetX":[122],"Dataworks,":[123],"database":[125],"health":[127,398],"records":[128],"claims":[130,395],"data":[131,643],"over":[133],"40":[134],"institutions.":[135],"Incidence":[136,508],"pneumonia/pneumonitis":[138],"was":[139,149,186,209,224,256],"estimated":[140],"billing":[142],"codes.":[143],"A":[144,620],"subgroup":[145,223],"158":[147,231],"selected":[150],"specific":[154],"code":[155],"group":[156],"confirmed":[158],"have":[160],"features":[161],"consistent":[162],"with":[163,276,307,311,418,448,485,518,542,566,652],"suspected":[164],"permitting":[166],"analysis":[167,299],"practices":[170],"outcomes.":[172],"To":[173,322],"describe":[174],"differences":[175],"utilization":[178],"survival,":[180,310],"second":[182],"propensity":[183],"generated":[187],"subgroup.":[190],"Results":[191],"The":[192],"attributable":[193],"risk":[194,599],"at":[203,300],"year":[205,271],"after":[206,240],"initiation":[208],"6.88%":[210],"(95%":[211,317],"CI":[212,318],"6.01\u20137.75%).":[213],"Median":[214],"time":[215],"onset":[217],"drug-induced":[219,266],"4.4":[225],"months":[226,302],"(IQR":[227],"2.1\u20137.8":[228],"months).":[229],"Of":[230],"patients,":[232],"21":[233],"(13.3%)":[234],"underwent":[235],"bronchoscopy":[236],"within":[237,262],"30":[238],"days":[239,264],"diagnosis.":[241],"Prednisone":[242],"(130/158,":[243],"82.3%),":[244],"methylprednisolone":[245],"(80/158,":[246],"50.6%),":[247],"antibiotics":[249],"(135/158,":[250],"85.4%)":[251],"prescribed.":[254],"discontinued":[257],"69.5%":[259],"90":[263],"pneumonitis.":[267],"Within":[268],"first":[270],"therapy,":[274],"had":[278,362],"more":[279],"hospitalizations":[280],"(83.5%":[281],"vs":[282,293],"49.4%,":[283],"RR":[284,295],"1.69,":[285],"p<0.0001)":[286],"ICU":[288],"requirements":[289],"than":[290,347,354],"controls":[291],"(28.5%":[292],"8.9%,":[294],"3.21,":[296],"p<0.0001).":[297],"Landmark":[298],"6":[301],"demonstrated":[303],"CIP":[305,331,361],"associated":[306,447,484,565],"reduced":[308],"overall":[309,372],"mortality":[313],"HR":[314],"1.43":[316],"1.03\u20131.97,":[319],"p=0.03).":[320],"Conclusions":[321],"our":[323],"knowledge,":[324],"this":[325],"largest":[328],"study":[329,336,622],"date.":[333],"Importantly,":[334],"found":[337],"PD-1/PD-L1-induced":[342],"pneumonitis,":[343],"6.88%,":[344],"higher":[346],"trial":[349],"estimates":[350],"(2\u20135%),":[351],"lower":[353],"reported":[355],"uncontrolled":[357],"studies":[359,384],"(17\u201319%).4\u20138":[360],"significant":[363],"negative":[364],"impacts":[365],"therapy":[367],"continuation,":[368],"survival":[373],"cancer.":[376,628],"This":[377],"work":[378],"demonstrates":[379],"proof":[380],"concept":[382],"irAE":[386],"incidences":[387],"patient":[389],"outcomes":[390],"feasible":[392],"electronic":[397],"record":[399],"databases.":[400],"References":[401],"Brahmer":[402],"JR,":[403],"Lacchetti":[404],"C,":[405],"Schneider":[406],"BJ,":[407],"et":[408,443,479,536,561,584],"al.":[409,444,480,537,562,585],"Management":[410,463],"treated":[417,541],"immune":[419,449,486,594],"therapy:":[422],"American":[423],"society":[424],"oncology":[427],"practice":[429],"guideline.":[430],"Journal":[431,466,549,575,601],"Clinical":[433,551,629],"Oncology":[434,495,527,552,604],"2018;36(17):1714\u20131768.":[435],"doi:10.1200/JCO.2017.77.6385.":[436],"Puzanov":[437],"I,":[438],"Diab":[439],"A,":[440,501,560],"Abdallah":[441],"K,":[442,579],"Managing":[445],"toxicities":[446,625],"inhibitors:":[451,488],"consensus":[452],"recommendations":[453],"Society":[456],"Immunotherapy":[458],"Cancer":[460,470,631],"(SITC)":[461],"Toxicity":[462],"Working":[464],"Group.":[465],"ImmunoTherapy":[468],"2017;5(1):95.":[471],"doi:10.1186/s40425-017-0300-z.":[472],"Wang":[473,532],"DY,":[474],"Salem":[475],"JE,":[476],"Cohen":[477],"JV,":[478],"Fatal":[481],"toxic":[482],"effects":[483],"systematic":[490,522],"review":[491,523],"meta-analysis.":[493,525],"JAMA":[494,526],"2018;4(12):1721\u20131728.":[496],"doi:10.1001/jamaoncol.2018.3923.":[497],"Nishino":[498],"M,":[499,556],"Giobbie-Hurder":[500],"Hatabu":[502],"H,":[503],"Ramaiya":[504],"NH,":[505],"Hodi":[506],"FS.":[507],"programmed":[510],"inhibitor-related":[514],"advanced":[519],"2016;2(12):1607\u20131616.":[528],"doi:10.1001/jamaoncol.2016.2453.":[529],"Naidoo":[530],"J,":[531,558],"X,":[533],"Woo":[534],"KM,":[535],"Pneumonitis":[538,586],"death-1/programmed":[544],"ligand":[546],"therapy.":[548],"2017;35(7):709\u2013717.":[553],"doi:10.1200/JCO.2016.68.2005.":[554],"Delaunay":[555],"Cadranel":[557],"Lusque":[559],"Immune-checkpoint":[563],"interstitial":[567],"disease":[569],"patients.":[572],"European":[573],"Respiratory":[574],"2017;50(2).":[576],"doi:10.1183/13993003.00050-2017.":[577],"Suresh":[578],"Voong":[580],"KR,":[581],"Shankar":[582],"B,":[583],"non\u2013small":[588],"receiving":[593],"immunotherapy:":[596],"factors.":[600],"Thoracic":[603],"2018;13(12):1930\u20131939.":[605],"doi:10.1016/j.jtho.2018.08.2035.":[606],"Cathcart-Rake":[607],"EJ,":[608],"Sangaralingham":[609],"LR,":[610],"Henk":[611],"HJ,":[612],"Shah":[613],"ND,":[614],"Riaz":[615],"I":[616],"bin,":[617],"Mansfield":[618],"AS.":[619],"population-based":[621],"immunotherapy-related":[624],"Lung":[630],"2020;21(5):421\u2013427.e2.":[632],"doi:10.1016/j.cllc.2020.04.003":[633],"Ethics":[634],"Approval":[635],"As":[636],"described":[637],"TriNetX9s":[639],"website":[640],"(https://trinetx.com/trinetx-publication-guidelines/),":[641],"all":[642],"available":[644],"network":[647],"de-identified":[649],"in-line":[651],"HIPAA":[653],"Privacy":[654],"Rule":[655],"standards.":[656]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2021-11-22T00:00:00"}